Viridian
Viridian is a Massachusetts-based biopharmaceutical firm that researches and develops antibody therapeutics to treat thyroid eye and autoimmune diseases.
Business Model:
Revenue: $1.9M
Employees: 11-50
Industries / Tags:
Detailed Viridian Information
Geographic Data
Address: 221 Crescent Street
City: Waltham
State: MA
Zip: 02453
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$75M
Raised Total:$75M
Social
Metrics
8,809,704Website Global Rank
259Website Monthly Traffic
Twitter Followers
Description
Viridian is a Massachusetts-based biopharmaceutical firm that researches and develops antibody therapeutics to treat thyroid eye and autoimmune diseases.
Contact Phone:
+16172724600
Contact Email:
Viridian went public on 4/24/2017 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/24/2017
IPO Valuation:
$287M
Ticker Symbol:
VRDN
IPO Price:
$11.73/share
Amount Raised:
$50M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 10/2020 | Viridian Therapeutics | |
| 11/2016 | Signal Genetics |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
